Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Healthier Choices Management Corp. Reports Second Quarter 2024 Financial Results

In This Article:

Healthier Choices Management Corp
Healthier Choices Management Corp

Sales of $15.6 million for the Second Quarter; $2.0 million Year-Over-Year Growth

Gross Margin of $5.9 million for the Second Quarter; $0.8 million Year-Over-Year Growth

HOLLYWOOD, FL, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Healthier Choices Management Corp. (OTC Pink: HCMC) today announced its financial results for the second quarter ended June 30, 2024.

Second Quarter 2024 Results and Recent Highlights:

  • Net sales from operations for the three-month period ended June 30, 2024, amounted to $15.6 million, compared to $13.6 million, an approximately $2.0 million and 15% increase versus the same period in 2023.

  • Gross margin from operations increased by approximately $0.8 million for the three-month period ended June 30, 2024, amounting to $5.9 million, compared to $5.1 million for the same period in 2023, a 16% year-over-year increase.

  • Adjusted EBITDA (Loss) for the three-month period ended June 30, 2024, amounted to approximately ($0.9 million) versus ($1.7 million) for the same period last year, a 44% year-over-year improvement.

Six Months 2024 Results and Recent Highlights:

  • Net sales from operations for the six-month period ended June 30, 2024, amounted to a record $31.5 million, compared to $27.1 million, an approximately $4.4 million and a 16% increase versus the same period in 2023.

  • Gross margin from operations increased by approximately $2.0 million for the six-month period ended June 30, 2024, amounting to $12.0 million, compared to $10.0 million for the same period in 2023, a 20% year-over-year increase.

  • Adjusted EBITDA (Loss) for the six-month period ended June 30, 2024, amounted to approximately ($2.2 million) versus ($3.2) million for the same period last year; a $1 million improvement versus the same period in 2023.

Jeffrey Holman, Chairman and CEO of HCMC, expressed his satisfaction with the company's performance in the second quarter. "Our long-term strategy for sales growth is starting to show results, as evidenced by our positive sales figures." Mr. Holman added, "The consistent increase in revenue and gross margin year over year highlights our ongoing progress. This strong second-quarter performance boosts our confidence in the strategic direction of HCMC."

Results of Operations:

The following table sets forth our Condensed Consolidated Statements of Operations for the three and six- months ended June 30, 2024 and 2023:

 

HEALTHIER CHOICES MANAGEMENT CORP.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(UNAUDITED)

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

June 30,

 

June 30,

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

Total sales, net

$

15,594,749

 

 

$

13,574,896

 

 

$

31,489,226

 

 

$

27,134,640

 

 

 

 

 

 

 

 

 

Total cost of sales

 

9,698,161

 

 

 

8,493,213

 

 

 

19,538,274

 

 

 

17,138,566

 

 

 

 

 

 

 

 

 

GROSS PROFIT

 

5,896,588

 

 

 

5,081,683

 

 

 

11,950,952

 

 

 

9,996,074

 

 

 

 

 

 

 

 

 

Total operating expenses

 

8,344,526

 

 

 

8,261,343

 

 

 

17,203,543

 

 

 

15,158,780

 

 

 

 

 

 

 

 

 

LOSS FROM OPERATIONS

 

(2,447,938

)

 

 

(3,179,660

)

 

 

(5,252,591

)

 

 

(5,162,706

)

 

 

 

 

 

 

 

 

Total other income (expense), net

 

(58,740

)

 

 

526,905

 

 

 

(115,234

)

 

 

602,650

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS) FROM CONTINUING OPERATIONS

$

(2,506,678

)

 

$

(2,652,755

)

 

$

(5,367,825

)

 

$

(4,560,056

)

 

 

 

 

 

 

 

 

See non-GAAP financial measure discussion

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

June 30,

 

June 30,

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

 

 

 

 

 

 

Loss from operations

$

(2,447,938

)

 

$

(3,179,660

)

 

$

(5,252,591

)

 

$

(5,162,706

)

Depreciation and amortization

 

378,146

 

 

 

374,022

 

 

 

757,694

 

 

 

747,485

 

Stock compensation

 

1,135,083

 

 

 

1,126,750

 

 

 

2,261,833

 

 

 

1,176,750

 

Adjusted EBITDA

$

(934,709

)

 

$

(1,678,888

)

 

$

(2,233,064

)

 

$

(3,238,471

)


Consolidated Balance Sheets